BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$0.93
-0.03 (-3.26%)
Financial Highlights (FY 2026)
Revenue
9.17M
Net Income
-2,390,864,439
Gross Margin
40.7%
Profit Margin
-26,074.4%
Rev Growth
—
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 40.7% | 52.9% | 52.9% | 52.9% |
| Operating Margin | -27,916.3% | -14.3% | -15.0% | -14.3% |
| Profit Margin | -26,074.4% | -10.2% | -10.2% | -13.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 9.17M | 1.16M | 1.19M | 1.27M |
| Gross Profit | 3.73M | 613.8K | 630.4K | 672.4K |
| Operating Income | -2,559,769,336 | -165,611 | -178,438 | -181,245 |
| Net Income | -2,390,864,439 | -117,803 | -121,826 | -173,784 |
| Gross Margin | 40.7% | 52.9% | 52.9% | 52.9% |
| Operating Margin | -27,916.3% | -14.3% | -15.0% | -14.3% |
| Profit Margin | -26,074.4% | -10.2% | -10.2% | -13.7% |
| Rev Growth | — | +16.9% | +20.6% | -0.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 948.8K | 1.10M | 1.01M |
| Total Equity | — | 2.62M | 2.50M | 2.62M |
| D/E Ratio | — | 0.36 | 0.44 | 0.39 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -2,547,384,014 | -246,829 | -223,977 | -272,889 |
| Free Cash Flow | — | -166,595 | -168,575 | -137,708 |